Evidence map›Paper›PMID 27446963›Full record

ArticleJournal of diabetes research2016

Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.

Ning Yan, Li Wen, Rui Peng, Hongmei Li, Handeng Liu, Huimin Peng, Yan Sun, Tianhui Wu, Lei Chen, Qingrui Duan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Meta-analysis Flavonoids from traditional Chinese herbs for diabetes in rats: a network Meta-analysi.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Ning YanMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Li WenMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China; Department of Cell Biology and Genetics, Chongqing Medical University, Chongqing 400016, China.ORCID 0000-0002-4081-635X
Rui PengDepartment of Bioinformatics, Chongqing Medical University, Chongqing 400016, China.
Hongmei LiChongqing Red Cross Hospital, Chongqing 400016, China.
Handeng LiuMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Huimin PengMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Yan SunMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Tianhui WuMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Lei ChenThe Second Clinical College, Chongqing Medical University, Chongqing 400016, China.
Qingrui DuanThe Second Clinical College, Chongqing Medical University, Chongqing 400016, China.
Yixuan SunThe Second Clinical College, Chongqing Medical University, Chongqing 400016, China.
Qin ZhouThe Second Clinical College, Chongqing Medical University, Chongqing 400016, China.
Lijiang WeiThe First Clinical College, Chongqing Medical University, Chongqing 400016, China.
Zheng ZhangMolecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China; Department of Cell Biology and Genetics, Chongqing Medical University, Chongqing 400016, China.ORCID 0000-0002-0062-517X
Chongqing Medical University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus (DM). However, the exact mechanism is not clearly understood. In this study, our results showed that 24 h urinary protein, kidney index, and glomerular area were decreased, while creatinine clearance ratio was increased in DN rats when the rats were treated with NAR 50 mg/d for 6 weeks. Mesangial cell (MMCs) proliferation was inhibited in the NAR group by 3,(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), and the cell cycle analysis showed that cells stayed in G2 phase in NAR group. And NAR treatment attenuated the deposition of ECM in DN rats and MMCs. Moreover, our data showed that let-7a was downexpressed in both DN rats and MMCs under high glucose condition. Surprisingly, NAR affected the expressions of Col4 and FN through upregulating let-7a in MMCs. In addition, we found that let-7a negatively regulated the expression of transforming growth factor-β1 receptor 1 (TGFBR1), and TGFBR1 was required for the let-7a-mediated downregulation of TGF-β1/smad signaling. Interestingly, NAR inhibited TGF-β1/smads signaling activation by upregulating let-7a. Therefore, our findings indicated that NAR ameliorated kidney injury by regulating let-7a/TGFBR1 signaling.

Indexed as

AnimalsBlood GlucoseDiabetes Mellitus, ExperimentalDiabetic NephropathiesFlavanonesKidneyMaleMicroRNAsProtein Serine-Threonine KinasesRatsRats, Sprague-DawleyReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISignal TransductionBlood GlucoseFlavanonesMicroRNAsMIRNLET7 microRNA, ratnaringeninProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, rat

Identifiers

PMID27446963
PMCPMC4944076
OpenAlexW2461457226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.